We offer niche product portfolio of APIs to customers, comprising innovators and generic players around the world. Our US FDA approved manufacturing facilities and GMP facilities are dedicated for APIs and Contract Manufacturing activities. These units support the manufacture of clinical trial materials and commercial products from kilogram upto multi ton levels. These plants consist of glass-lined and stainless-steel reactors, with size ranging from 50L to 14,000L with a total installed reactor capacity of 180 cubic meters. Our highly skilled route scouting and process development teams are supported by effective supply chain, IP, Analytical Development, QC, QA, Manufacturing and program management teams. 

Our combined expertise in route selection, process development, cGMP, scale-up, comprehensive manufacturing capability and equipments are competitive in all phases of drug development. We can be your sole API and Intermediate resource, right from the pre-clinical phase through to the commercialization of your product, while also streamlining and shortening the entire process.

We will only supply products where allowed to, by law and which comply with global IP regulations.  We look forward to discussing your specific API requirements and developing a joint approach to support your market plans.